Strategic Investment Advisors Abbott Laboratories Transaction History

Strategic Investment Advisors

$909 Million
Q3 2024

A detailed history of Strategic Investment Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Strategic Investment Advisors holds 7,347 shares of ABT stock, worth $845,125. This represents 0.09% of its overall portfolio holdings.

Number of Shares

7,347

Previous 7,842 6.31%

Holding current value

$845,125

Previous $814,000 2.83%

% of portfolio

0.09%

Previous 0.1%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$100.07 - $118.13 $49,534 - $58,474	-495 Reduced 6.31%	7,347 $837,000
Q2 2024 Jul 22, 2024	BUY	$100.73 - $112.44 $31,830 - $35,531	316 Added 4.2%	7,842 $814,000
Q1 2024 Apr 22, 2024	BUY	$109.52 - $120.96 $29,241 - $32,296	267 Added 3.68%	7,526 $855,000
Q4 2023 Jan 10, 2024	SELL	$90.19 - $110.4 $59,074 - $72,312	-655 Reduced 8.28%	7,259 $798,000
Q3 2023 Oct 24, 2023	SELL	$95.53 - $114.62 $16,526 - $19,829	-173 Reduced 2.14%	7,914 $766,000
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $94,632 - $105,440	939 Added 13.14%	8,087 $881,000
Q1 2023 Apr 27, 2023	SELL	$96.86 - $114.01 $638,501 - $751,553	-6,592 Reduced 47.98%	7,148 $723,000
Q4 2022 Jan 19, 2023	BUY	$95.06 - $111.52 $240,311 - $281,922	2,528 Added 22.55%	13,740 $0
Q3 2022 Oct 27, 2022	SELL	$96.76 - $112.03 $5,805 - $6,721	-60 Reduced 0.53%	11,212 $1.09 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $10,921 - $13,200	-107 Reduced 0.94%	11,272 $1.23 Million
Q1 2022 Apr 28, 2022	SELL	$114.02 - $139.04 $28,390 - $34,620	-249 Reduced 2.14%	11,379 $1.35 Million
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $6,585 - $8,063	57 Added 0.49%	11,628 $1.64 Million
Q3 2021 Oct 19, 2021	BUY	$116.66 - $129.06 $87,844 - $97,182	753 Added 6.96%	11,571 $1.37 Million
Q2 2021 Jul 22, 2021	BUY	$105.79 - $124.53 $315,148 - $370,974	2,979 Added 38.0%	10,818 $1.25 Million
Q1 2021 Apr 14, 2021	BUY	$108.84 - $128.23 $76,623 - $90,273	704 Added 9.87%	7,839 $939,000
Q4 2020 Jan 13, 2021	BUY	$105.0 - $114.42 $108,255 - $117,967	1,031 Added 16.89%	7,135 $781,000
Q3 2020 Oct 14, 2020	BUY	$91.64 - $111.29 $79,910 - $97,044	872 Added 16.67%	6,104 $664,000
Q2 2020 Aug 04, 2020	BUY	$76.57 - $98.0 $27,794 - $35,574	363 Added 7.46%	5,232 $478,000
Q1 2020 Apr 13, 2020	BUY	$62.82 - $91.86 $99,820 - $145,965	1,589 Added 48.45%	4,869 $384,000
Q4 2019 Jan 23, 2020	SELL	$78.51 - $87.4 $157 - $174	-2 Reduced 0.06%	3,280 $285,000
Q3 2019 Oct 25, 2019	BUY	$81.84 - $88.74 $1,636 - $1,774	20 Added 0.61%	3,282 $275,000
Q2 2019 Jul 23, 2019	BUY	$72.88 - $85.0 $237,734 - $277,270	3,262 New	3,262 $274,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

News

Stay updated on Strategic Investment Advisors with notifications on news.

Account

Strategic Investment Advisors Abbott Laboratories Transaction History